rus
Gynecologic Oncology

Gynecologic Oncology #3'2012

Content

EDITORIAL
Zhordania K.I. SEROUS OVARIAN CARCINOMA OR SEROUS CARCINOMA OF UTERINE (FALLOPIAN) TUBE? 4
The review article examines the hypothesis of the role of fallopian tube epithelium in ethiopathogenesis of serous ovarian carcinoma based on morphological and molecular genetic studies.
 Full text (in Russian)
FUNDAMENTAL ONCOLOGY
Paianidi Ju.G., Kazubskaya T.P., Selchiuk V.Ju., Kashurnikov A.Ju., Ogai D.S., Nasedkina T.V. HORMONAL CONTRACEPTION AND CANCER: PROS AND CONS 10
The article highlights the risk groups for the occurrence of solitary and multiple primary cancer of the organs of female reproductive system and the ways of its prevention. The material is presented on the basis of the authors’ own observations, as well as with the consideration of international research experience.
 Full text (in Russian)
UTERINE CANCER
Popov A.A., Ramazanov M.R., Fedorov A.A., Slobodianuk B.A. VAGINAL HYSTERECTOMY USING ELECTROLIGATION WITH BIPOLAR COAGULATION FORCEPS BICLAMP 17
The article presents the results of the surgical treatment of the patients with uterus pathology by vaginal hysterectomy using electroligation with bipolar coagulation forceps BICLAMP.
 Full text (in Russian)
OVARIAN CANCER
Artamonova E.V., Manziuk L.V., Panichenko I.V. EVOLUTION OF PRIMARY OVARIAN CANCER CHEMOTHERAPY ACCORDING TO CLINICAL TRIAL DATA OF PACLITAXEL 22
The article presents the clinical trial data on the use of different combinations of Paclitaxel in the treatment of primary ovarian cancer.
 Full text (in Russian)
Khokhlova S.V. THE ROLE OF BEVACIZUMAB IN THE TREATMENT OF OVARIAN CANCER 33
Angiogenesis plays an important role in the development and metastasis of ovarian cancer. Bevacizumab, which is the most studied angiogenesis inhibitor in the treatment of ovarian cancer, demonstrated high effectiveness both with recurrence and with fi rst-line.
 Full text (in Russian)
BREAST CANCER
Korzhenkova G.P. FIBROCYSTIC MASTOPATHY IS A DISEASE OR NORMAL VARIANT? 46
The clinical lecture presents a review of the reported data on the pathogenesis and diagnosis of fi brocystic mastopathies. It discusses the approaches in the evaluation of clinical and diagnostic algorithms. The role of progesterone in the pathogenesis of such changes.
 Full text (in Russian)
Ryabchikov D.F., Portnoy S.М., Vorotnikov I.K., Chkhikvadze N.V. THE ROLE OF IMMUNOHISTOCHEMICAL MARKERS AS PREDICTIVE FACTORS IN EFFECTIVENESS OF PREOPERATIVE CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER 56
Discussed the prognostic role of markers Pgp-170, Нer2, Ki67 in patients with breast cancer.
 Full text (in Russian)
Zakharova N.А. THE RESULT OF FIVE-YEAR IMPLEMENTATION OF THE SCREENING PROGRAM FOR EARLY BREAST CANCER DIAGNOSIS IN KHANTY-MANSIYSKY STATE REGION — UGRA 62
The main purpose of the study is to evaluate the fi ve-year results for the Breast Cancer Screening Program in the Khanty- Mansiysky Autonomous Okrug — Ugra during 2007–2011 years. The strategy of the screening is: age — over 40 years old; screening interval — every 2 years; 2-view mammography; single reading. During the period 2007–2011 there are 201668 women have been screened in the region. There are 482 breast cancer cases have been detected within screening program. The coverage rate estimated as 56,4%. The cancer detection rate is 2,5 per 1000 screened women. 10,3% of screened women were referred for further assessment. Thus, in the future in Ugra is planned to continue the Breast Cancer Screening Program, also have been identifi ed the main ways for the improving of the quality of screening.
 Full text (in Russian)
INTERDISCIPLINARY QUESTIONS
Krasnopolskaya K.V., Nazarenko T.A., Balakhontseva O.S. Preservation of reproductive function in women with oncological diseases (clinical lecture). 66
The article discusses existing approaches to the preservation of reproductive potential in women with oncological diseases, including organ-preserving operations and methods of reducing and minimizing of gonadotoxic effects of anti-tumor therapy as well as assisted reproductive technologies combined with cryoconservation technologies.
 Full text (in Russian)
 Reader's information 74
 Instructions 77